Dermatology News
- HPV Vaccine May Cut Actinic Keratosis Burden
- AAD 2025 Dupilumab Shown to Reduce Symptoms, Steroid Use in BP
- VEXAS and Related Syndromes Share Immune Signatures
- Chronic Skin Effects Persist After Cancer Immunotherapy
- Deucravacitinib Meets Endpoints in Phase 3 PsA Trial
- Upadacitinib Shows Efficacy in Refractory Crohn's Disease
- AAD 2025 AI-Based Skin Cancer Screen Effective in Real World
- AAD 2025 Investigational Alopecia Areata Drug Shows Sustained Effect
- Measles Cases in Texas, New Mexico Rise by 28 in Five Days as Outbreak Spreads
- MetS and Radiographic Damage in PsA: Is There a Link?
- AAD 2025 Delusional Dermatoses Tamed by 'Therapeutic Alliance'
- AAD 2025 Delgocitinib Cream Produces Robust Response to Eczema
- AAD 2025 Potentially Harmful Cosmetics Peddled to Young Girls
- AAD 2025 Therapeutic Advances Help Curb Hyperhidrosis
- Poor Air Quality Linked to AD Risk in Offspring
- Doctors Push Back as Parents Embrace Kennedy and Vitamin A in Texas Measles Outbreak
- Remibrutinib Yields Rapid, Sustained Relief in Urticaria
- Low-Dose Minocycline Bests Doxycycline as Rosacea Rx
- Nigeria to Receive Leprosy Drugs After a Year-long Delay
- From Fighting HIV to Interpreters, USAID Cuts Wide Swath of Programs